Skip to main content
. 2024 Jun 15;14(6):3130–3141. doi: 10.62347/JOVT3911

Table 2.

Comparison of related factors before and after therapy in patients

Index Before therapy After treatment t P
WBC (109/L) 7.22±2.24 6.59±2.73 2.880 0.005
HGB (g/L) 130.53±18.67 119.87±18.67 7.127 0.000
PLT (109/L) 153.11±85.94 239.03±85.38 2.052 0.042
ANC (109/L) 4.93±1.96 4.39±2.65 2.494 0.014
ALC (109/L) 1.51±0.56 1.45±0.55 1.196 0.234
AMC (109/L) 0.54±0.24 0.56±0.25 -0.881 0.380
NLR (%) 3.77±2.27 3.60±2.86 0.604 0.547
PLR (%) 192.55±110.73 183.18±89.59 0.908 0.365
LMR (%) 3.38±2.61 3.03±1.68 1.436 0.153
ALB (g/L) 36.56±4.53 36.81±5.48 -0.500 0.618
TC (mmol/L) 4.23±0.86 4.44±1.02 -2.676 0.008
TG (mmol/L) 1.29±0.71 1.43±0.72 -1.996 0.048
HDL (mmol/L) 1.19±0.31 1.26±0.39 -2.349 0.020
LDL (mmol/L) 2.79±0.71 2.87±0.84 -1.408 0.162
APO-A1 (g/L) 1.17±0.27 1.19±0.29 -0.628 0.531
APO-B (g/L) 0.85±0.22 0.88±0.27 -1.889 0.061

Notes: WBC, white blood cell; HGB, hemoglobin; PLT, platelets; ANC, absolute neutrophil count; ALC, lymphocyte count; AMC, monocyte count; NLR, neutrophil/lymphocyte ratio; PLR, platelet/lymphocyte ratio; LMR, lymphocyte/monocyte ratio; ALB, albumin; TC, cholesterol; TG, triglyceride; HDL, high density lipoprotein; LDL, low density lipoprotein; APO-A1, apolipoprotein A1; APO-B, apolipoprotein B.